Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Parent views vary on young people receiving aesthetic treatments like laser hair removal, chemical skin peels, teeth whitening, and dermal fillers, national poll finds.